Entera Bio Profit Margin 2018-2021 | ENTX
Current and historical gross margin, operating margin and net profit margin for Entera Bio (ENTX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Entera Bio net profit margin as of June 30, 2021 is -3414.71%.
|Entera Bio Annual Profit Margins
|Entera Bio Quarterly Profit Margins
||Medical - Biomedical and Genetics
Entera Bio Ltd. is a clinical-stage biopharmaceutical company. It focused on the development and commercialization of orally delivered molecule therapeutics for use in orphan indications and other areas with significant unmet medical need. The Company is initially applying its technology to develop an oral formulation of parathyroid hormone for hypoparathyroidism and osteoporosis. Entera Bio Ltd. is based in Jerusalem, Israel.